687 related articles for article (PubMed ID: 30525949)
1. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
4. [Intestinal immune response is regulated by gut microbe].
Tanemoto S; Sujino T; Kanai T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
[TBL] [Abstract][Full Text] [Related]
5. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?
Rinaldi E; Consonni A; Guidesi E; Elli M; Mantegazza R; Baggi F
Ann N Y Acad Sci; 2018 Feb; 1413(1):49-58. PubMed ID: 29341125
[TBL] [Abstract][Full Text] [Related]
7. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
Khanna S; Raffals LE
Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
[TBL] [Abstract][Full Text] [Related]
8. Gut environmental factors and multiple sclerosis.
Miyake S; Yamamura T
J Neuroimmunol; 2019 Apr; 329():20-23. PubMed ID: 30077395
[TBL] [Abstract][Full Text] [Related]
9. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton G; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
[No Abstract] [Full Text] [Related]
10. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
12. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
13. The microbiome in autoimmune diseases.
De Luca F; Shoenfeld Y
Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
[TBL] [Abstract][Full Text] [Related]
14. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
15. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
16. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
17. The potential of fecal microbiota transplantation in systemic sclerosis.
Hoffmann-Vold AM; Fretheim H; Didriksen H; Molberg Ø
Expert Rev Clin Immunol; 2020 Feb; 16(2):117-118. PubMed ID: 31858856
[No Abstract] [Full Text] [Related]
18. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
19. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
20. Human microbiome restoration and safety.
Daliri EB; Tango CN; Lee BH; Oh DH
Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
